If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vito Di Marco is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 90 Similar Profiles
Fibrosis Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Genotype Medicine & Life Sciences
Liver Medicine & Life Sciences
Liver Cirrhosis Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D.

Bronte, F., Craxi, A., Di Marco, V., Calvaruso, V., Colombo, M., Levrero, M., Andreone, Scuteri, Vukotic, R., Bronte, Calvaruso, V., Rastelli, Rizzetto, M., Brunetto, M. R., Gaeta, G. B., Lenisa, Mangia, Dissegna, Chessa, L., Lembo & 28 others, Raimondo, G., Rizzo, Santantonio, T., Subic, Brancaccio, G., Antonio, Antonio, Antonio, Caccianotti, Marchese, Pierconti, Rozzi, A., Ciarallo, Bruzzone, D'Aluisio, Scuteri, A., Coco, B., Colombatto, P., Demelia, Cursaro, Toniutto, Invernizzi, Di Marco, V., Lampertico, P., Picciotto, A., Squadrito, G., Caccamo, G. & Sorbello, 2019, In : Journal of Viral Hepatitis. 26, p. 118-125 8 p.

Research output: Contribution to journalArticle

Hepatitis B e Antigens
Chronic Hepatitis B
Genotype
Hepatitis B Surface Antigens
Therapeutics
Aminopyrine
Breath Tests
Hepacivirus
Antiviral Agents
Fibrosis
Phospholipases
Hepatocellular Carcinoma
Liver
Liver Cirrhosis
Genes

Current andforthcoming perspectives in linkage to care of hepatitis C virusinfection:Assessment of an Italian focus group.

Craxi, A., Di Marco, V., Andreone, P., Vukotic, R., Gaeta, G. B. & Fagiuoli, S., 2019, In : Digestive and Liver Disease. 7 p.

Research output: Contribution to journalArticle

Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Licata, A., Calvaruso, V., Petta, S., Di Marco, V., Celsa, C., Craxi, A., Camma', C., Cabibbo, G., Alaimo, G., Benanti, F., Scifo, G., Madonia, S., Raimondo, G., Licata, A., Averna, A., Distefano, M., Di Rosolini, M. A., Mazzola, G., Prestileo, T., Cannavò, M. R. & 12 others, Larocca, L., Cartabellotta, F., Scalisi, I., Malizia, G., Cacciola, I., Russello, M., Bertino, G., Trevisani, F., Squadrito, G., Magro, B., Rini, F. & Alessi, N., 2019, p. e36-e37. 2 p.

Research output: Contribution to conferenceOther

Hepacivirus
Antiviral Agents
Hepatocellular Carcinoma
Survival
Therapeutics

Projects 2005 2005